Evidence map›Paper›PMID 31583990›Full record

ArticleThe British journal of nutrition2020

Plasma polyphenols associated with lower high-sensitivity C-reactive protein concentrations: a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Laura M Harms, Augustin Scalbert, Raul Zamora-Ros, Sabina Rinaldi, Mazda Jenab, Neil Murphy, David Achaintre, Anne Tjønneland, Anja Olsen, Kim Overvad and 27 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in The British journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. The Role of Ferulic Acid in Selected Malignant Neoplasms.Molecules (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 12 countries.

Laura M HarmsNutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), 14558 Nuthetal, Germany.
Augustin ScalbertInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.
Raul Zamora-RosUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.ORCID 0000-0002-6236-6804
Sabina RinaldiInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.
Mazda JenabInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.
Neil MurphyInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.
David AchaintreInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.
Anne TjønnelandDanish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Anja OlsenDanish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Kim OvervadDepartment of Public Health, Aarhus University, DK-8000 Aarhus C, Denmark.
Francesca Romana ManciniCESP, faculté de médecine, université Paris-Sud, 75006 Paris, France.
Yahya Mahamat-SalehCESP, faculté de médecine, université Paris-Sud, 75006 Paris, France.
Marie-Christine Boutron-RuaultCESP, faculté de médecine, université Paris-Sud, 75006 Paris, France.
Tilman KühnDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Antonia TrichopoulouHellenic Health Foundation, 11527 Athens, Greece.
Georgia MartimianakiHellenic Health Foundation, 11527 Athens, Greece.
Anna KarakatsaniHellenic Health Foundation, 11527 Athens, Greece.
Domenico PalliMolecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute- ISPO, 50139 Firenze, Italy.
Salvatore PanicoEPIC Centre of Naples, Dipartimento di Medicina Clinica e Chirurgia Federico II University, 80131 Napoli, Italy.
Sabina SieriEpidemiology and Prevention UnitFondazione Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
Rosario TuminoCancer Registry and Histopathology Unit, "Civic-M.P. Arezzo" Hospital, 97100 Ragusa, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), 10126 Turin, Italy.
Bas Bueno-de-MesquitaDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK.
Roel C H VermeulenDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.
Therese Haugdahl NøstDepartment of Community Medicine, University of Tromsø, The Arctic University of Norway, 9019 Tromsø, Norway.
Cristina LasherasDepartment of Functional Biology, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.
Miguel Rodríguez-BarrancoAndalusian School of Public Health (EASP), Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Universidad de Granada, 18011 Granada, Spain.
José María HuertaCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Aurelio BarricarteCIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Miren DorronsoroPublic Health Direction and Biodonostia-Ciberesp, Basque Regional Health Department, 20014 Donostia-San Sebastián, Spain.
Johan HultdinUmeå University, Medical Biosciences, Clinical Chemistry, 901 87 Umeå, Sweden.
Julie A SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
Marc GunterInternational Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK.
Krasimira AleksandrovaNutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), 14558 Nuthetal, Germany.
Centre international de recherche sur le cancer · FRUniversité Paris-Sud · FRGerman Cancer Research Center · DENational and Kapodistrian University of Athens · GRAarhus University · DKAzienda Usl 8 Arezzo · ITBiogipuzkoa Health Research Institute · ESDanish Cancer Society · DKFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEHellenic Health Foundation · GRImperial College London · GBInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Salud Pública de Navarra · ESInstituto Murciano de Investigación Biosanitaria · ESPiedmont Reference Center for Epidemiology and Cancer Prevention · ITPrevention Institute · USUiT The Arctic University of Norway · NOUmeå University · SEUniversidad de Granada · ES

Funding

Cancer Research UK 14136Cancer Research UK C8221/A19170Medical Research Council 1000143Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

Experimental studies have reported on the anti-inflammatory properties of polyphenols. However, results from epidemiological investigations have been inconsistent and especially studies using biomarkers for assessment of polyphenol intake have been scant. We aimed to characterise the association between plasma concentrations of thirty-five polyphenol compounds and low-grade systemic inflammation state as measured by high-sensitivity C-reactive protein (hsCRP). A cross-sectional data analysis was performed based on 315 participants in the European Prospective Investigation into Cancer and Nutrition cohort with available measurements of plasma polyphenols and hsCRP. In logistic regression analysis, the OR and 95 % CI of elevated serum hsCRP (>3 mg/l) were calculated within quartiles and per standard deviation higher level of plasma polyphenol concentrations. In a multivariable-adjusted model, the sum of plasma concentrations of all polyphenols measured (per standard deviation) was associated with 29 (95 % CI 50, 1) % lower odds of elevated hsCRP. In the class of flavonoids, daidzein was inversely associated with elevated hsCRP (OR 0·66, 95 % CI 0·46, 0·96). Among phenolic acids, statistically significant associations were observed for 3,5-dihydroxyphenylpropionic acid (OR 0·58, 95 % CI 0·39, 0·86), 3,4-dihydroxyphenylpropionic acid (OR 0·63, 95 % CI 0·46, 0·87), ferulic acid (OR 0·65, 95 % CI 0·44, 0·96) and caffeic acid (OR 0·69, 95 % CI 0·51, 0·93). The odds of elevated hsCRP were significantly reduced for hydroxytyrosol (OR 0·67, 95 % CI 0·48, 0·93). The present study showed that polyphenol biomarkers are associated with lower odds of elevated hsCRP. Whether diet rich in bioactive polyphenol compounds could be an effective strategy to prevent or modulate deleterious health effects of inflammation should be addressed by further well-powered longitudinal studies.

Indexed as

Nutrition AssessmentAdultAgedBiomarkersCohort StudiesC-Reactive ProteinCross-Sectional StudiesDietDiet SurveysEuropeFemaleHumansInflammationMaleMiddle AgedNeoplasmsBiomarkersC-Reactive ProteinPolyphenolsChronic diseasesC-reactive proteinInflammationPlasma measurementsPolyphenols

Identifiers

PMID31583990
PMCPMC7015881
OpenAlexW2979168243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.